Familial Colorectal Cancer Type X
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Evaluation of additional FCCX families for mutations in RPS20 and other ribosome-associated genes is warranted.
|
24941021 |
2014 |
Lupus Erythematosus, Systemic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Transancestral mapping and genetic load in systemic lupus erythematosus.
|
28714469 |
2017 |
Colorectal Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We therefore found published evidence to support the association between variants in NTHL1 and RPS20 with CRC, but not of other recently reported CRC susceptibility variants.
|
27713038 |
2017 |
Colorectal Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We provide an overview of newly described genes and syndromes associated with predisposition to CRC and polyposis, including: polymerase proofreading-associated polyposis, NTHL1-associated polyposis, mismatch repair gene biallelic inactivation-related adenomatous polyposis (including MSH3- and MLH3-associated polyposes), GREM1-associated mixed polyposis, RNF43-associated serrated polyposis, and RPS20 mutations as a rare cause of hereditary nonpolyposis CRC.
|
30862463 |
2019 |
Malignant tumor of colon
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Genetic linkage analysis, exome sequencing, tumor studies, and functional investigations of 4 generations of a FCCX family led to the identification of a truncating germline mutation in RPS20, which encodes a component (S20) of the small ribosomal subunit and is a new colon cancer predisposition gene.
|
24941021 |
2014 |
Cardiovascular Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We evaluated two PTGS2 (rs20417, rs689470), and three PTGER2 (rs708494/uS5, rs708495/uS7, and chr14: 50 764 013/uS10) gene polymorphisms among 600 Caucasian male participants of the Physicians' Health Study with incident myocardial infarction (MI) or ischemic stroke and 600 age- and smoking-matched controls who remained free of all reported cardiovascular disease.
|
16879213 |
2006 |
Lymphoma, Follicular
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mean per-patient, per-month cost during follow-up was US$11,890 for DLBCL and US$10,460 for FL.
|
29911900 |
2018 |
Medulloblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that gain of 8q and expression levels of three 8q-mapped candidate genes (EEF1D, RPL30, RPS20) are associated with adverse outcome in medulloblastoma.
|
16968546 |
2006 |
Myocardial Infarction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We evaluated two PTGS2 (rs20417, rs689470), and three PTGER2 (rs708494/uS5, rs708495/uS7, and chr14: 50 764 013/uS10) gene polymorphisms among 600 Caucasian male participants of the Physicians' Health Study with incident myocardial infarction (MI) or ischemic stroke and 600 age- and smoking-matched controls who remained free of all reported cardiovascular disease.
|
16879213 |
2006 |
Adenomatous Polyposis Coli
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We provide an overview of newly described genes and syndromes associated with predisposition to CRC and polyposis, including: polymerase proofreading-associated polyposis, NTHL1-associated polyposis, mismatch repair gene biallelic inactivation-related adenomatous polyposis (including MSH3- and MLH3-associated polyposes), GREM1-associated mixed polyposis, RNF43-associated serrated polyposis, and RPS20 mutations as a rare cause of hereditary nonpolyposis CRC.
|
30862463 |
2019 |
Diffuse Large B-Cell Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mean per-patient, per-month cost during follow-up was US$11,890 for DLBCL and US$10,460 for FL.
|
29911900 |
2018 |
Childhood Medulloblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that gain of 8q and expression levels of three 8q-mapped candidate genes (EEF1D, RPL30, RPS20) are associated with adverse outcome in medulloblastoma.
|
16968546 |
2006 |
Adult Medulloblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that gain of 8q and expression levels of three 8q-mapped candidate genes (EEF1D, RPL30, RPS20) are associated with adverse outcome in medulloblastoma.
|
16968546 |
2006 |
Central Diabetes Insipidus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Inpatients for whom CDI was the main reason for hospitalization incurred mean costs of US$10,528 and an average LOS of 5.9 days.
|
30690052 |
2019 |
Colon Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Genetic linkage analysis, exome sequencing, tumor studies, and functional investigations of 4 generations of a FCCX family led to the identification of a truncating germline mutation in RPS20, which encodes a component (S20) of the small ribosomal subunit and is a new colon cancer predisposition gene.
|
24941021 |
2014 |
Ischemic stroke
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We evaluated two PTGS2 (rs20417, rs689470), and three PTGER2 (rs708494/uS5, rs708495/uS7, and chr14: 50 764 013/uS10) gene polymorphisms among 600 Caucasian male participants of the Physicians' Health Study with incident myocardial infarction (MI) or ischemic stroke and 600 age- and smoking-matched controls who remained free of all reported cardiovascular disease.
|
16879213 |
2006 |
Hereditary nonpolyposis colorectal carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Familial Colorectal Cancer Type X
|
0.320 |
Biomarker
|
disease |
BEFREE |
Recent studies describe the correlation between FCCTX and genes such as BRCA2, SEMA4, NTS, RASSF9, GALNT12, KRAS, BRAF, APC, BMPR1A, and RPS20.
|
29096939 |
2018 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary non-polyposis colorectal cancer syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary non-polyposis colorectal cancer syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
|
24941021 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |
Hereditary Non-Polyposis Colon Cancer Type 2
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
|
27713038 |
2017 |